AI Verdict
INGM has stronger fundamentals based on our AI analysis.
INO vs INGM Fundamental Comparison
| Metric | INO | INGM |
|---|---|---|
| Revenue | $65,343.0 | $52.6B |
| Net Income | $-84.9M | $327.9M |
| Net Margin | -130,000.0% | 0.6% |
| ROE | -352.5% | 7.7% |
| ROA | -114.3% | 1.5% |
| Current Ratio | 1.40x | 1.33x |
| Debt/Equity | 2.60x | 0.75x |
| EPS | $-1.81 | $1.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
INO vs INGM: Frequently Asked Questions
Is INO or INGM a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), INGM has stronger fundamentals. INO is rated STRONG SELL (92% confidence) while INGM is rated BUY (72% confidence). This is not investment advice.
How does INO compare to INGM fundamentally?
INOVIO PHARMACEUTICALS, INC. has ROE of -352.5% vs Ingram Micro Holding Corp's 7.7%. Net margins are -130,000.0% vs 0.6% respectively.
Which stock pays higher dividends, INO or INGM?
INO has a dividend yield of N/A or no dividend while INGM has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in INO or INGM for long term?
For long-term investing, consider that INO has STRONG SELL rating with 92% confidence, while INGM has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about INO vs INGM?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For INO vs INGM, the AI consensus favors INGM based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.